Pregnancy is supposed to be a time of joy and anticipation, but for some expectant mothers, it’s anything but. Imagine being so sick that you can’t keep down food, water, or even your own saliva—day after day, week after week. This isn’t just ‘morning sickness’; it’s hyperemesis gravidarum (HG), a severe and often misunderstood condition that can turn the dream of motherhood into a living nightmare. But here’s where it gets controversial: while HG affects a small percentage of pregnancies, the lack of consistent treatment options and support leaves many women feeling abandoned by the healthcare system. And this is the part most people miss: the emotional and physical toll of HG can be so devastating that some women are forced to make impossible choices, like terminating a wanted pregnancy. Let’s dive into the stories of these brave women and explore why access to effective treatments, like the drug Xonvea, remains a postcode lottery.
When BBC reporter Beth Parsons was diagnosed with HG during her pregnancy, she was thrust into a world of relentless nausea and vomiting. ‘I lost three stone and was sick 40 times a day,’ shared Millie Fitzsimons, another sufferer. Beth’s experience was no less harrowing. She recalls drawing the curtains on a sunny afternoon, desperate to avoid another bout of sickness, and wondering when she’d feel like herself again. ‘It’s isolating, lonely, and incredibly hard to explain,’ she says. While ‘normal’ morning sickness is often brushed off as a rite of passage—something ginger tea or rest can fix—HG is a different beast entirely. It’s a condition that can rob women of their ability to eat, drink, or even function, all while they’re supposed to be nurturing a growing life inside them.
Beth’s journey eventually led her to a medication that helped, but not before she felt the weight of guilt for struggling during what should have been a happy time. ‘I felt so lucky to be starting a family, and yet I was miserable,’ she admits. Her story is not unique. After sharing her experience online, other women came forward with their own tales of suffering, highlighting the stark disparities in the support and treatments available across the UK.
Take Sarah Goddard, for example. Pregnant with her second child, she endured vomiting so severe that she was hospitalized multiple times. ‘I thought I was dying,’ she recalls. Despite her pleas for help, the medication she needed was out of reach. At 10 weeks, she made the heart-wrenching decision to terminate her pregnancy. ‘I still feel devastated,’ she says. ‘I was trying to give my daughter a sibling, and I had to take it away.’ Sarah’s story raises a troubling question: Why are women like her being failed by the system?
Then there’s Millie Fitzsimons, who was admitted to the hospital 16 times during her pregnancy. She describes HG as ‘a feeling you can’t explain—like you’re dying.’ Despite her desperate need for relief, accessing Xonvea, the medication that eventually helped her, was a battle. ‘They said it was a postcode lottery,’ she explains. It wasn’t until she moved to a different area that she finally received the treatment she needed. But by then, the damage was done. Millie was off work for eight months and doubts she’ll ever have another child.
Ella Marcham’s story is equally heartbreaking. Already a mother of two toddlers, she faced HG before she even knew she was pregnant with twins. ‘The nausea never stopped—24/7,’ she says. Despite begging her GP and hospital for Xonvea, she was repeatedly denied. ‘I was at such a low point, I just didn’t have the energy to keep fighting,’ she admits. The cost of accessing the medication privately—£86.95 for less than a week’s supply—was simply out of reach. Yet, as soon as her twins were born, her symptoms vanished, leaving her to wonder why she had to suffer so much during her pregnancy.
HG is estimated to affect 1-3% of pregnancies, yet its impact is profound. Dehydration, weight loss, and an inability to function are common, and many women require medication and intravenous fluids just to survive. But here’s the kicker: Xonvea, the only anti-sickness drug licensed for use in pregnancy in the UK, is often withheld due to cost or caution. Doncaster GP Dr. Dean Eggitt explains, ‘We’re extremely cautious about using new medications in pregnant women.’ While safety is paramount, this caution can feel like indifference to women who are desperate for relief. ‘It’s a postcode lottery,’ he admits, echoing the frustrations of so many sufferers.
The charity Pregnancy Sickness Support is campaigning for Xonvea to be included on all drug formularies, ensuring consistent access for all women. But the question remains: Why is a condition that can cause such devastation still so poorly understood and treated? Is it fair that a woman’s ability to access life-changing medication depends on where she lives? And what more can be done to support women who are forced to make impossible choices because of HG?
If you’ve been affected by HG or know someone who has, you’re not alone. Support is available, and your story matters. Let’s keep the conversation going—because no woman should have to suffer in silence. What’s your take on the treatment and support available for HG? Do you think more needs to be done? Share your thoughts in the comments below.
